Green Cross signs Korean distribution agreement of ‘Diterin Tab’ with Alvogen Korea

Published: 2017-02-06 14:14:09

Updated: 2017-02-06 14:14:09

On the 2^nd, Green Cross(CEO Eun-Cheol Huh) announced an Korean distribution agreement of the phenylketonuria treatment ‘Diterin Tab’ with Alvogen Korea(CEO Young0Hee Jang).

Under the agreement, Green Cross will take charge in distribution of ‘Diterin Tab’ in Korea for 5 years by 2021.

Phenylketonuria(PKU) is an inborn error of metabolism that results in essential enzymes required in metabolis...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.